Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

RxMx

We’re a healthcare company with exceptional technology solutions and longstanding industry experience. Founded by doctors, we’ve built our business on the idea that by automating certain tasks, we can empower HCPs to safely administer specialty medicines without increasing their burden, so they can focus on patients who need their care.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Genetic Digital

We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…

View Profile

Creative and design, Digital communications, IT solutions, Marketing consultancies, Medical communications

- PMLiVE

Nmblr

From day-one concept to launch and beyond, Nmblr is the strategy and collaboration platform that partners with biopharma teams.

View Profile

IT solutions

Company Details

RxMx
800 Third Avenue, Suite 2800, New York, New York, 10022, United States
(844) 311 3080
Contact RxMx
Website

 Latest Content from PMHub 

OPEN Health has been awarded a Bronze Medal by EcoVadis

White Papers and Resources | September 7, 2020 | OPEN Health

We are delighted to announce that OPEN Health has been awarded a Bronze Medal by EcoVadis for its very first Corporate Social Responsibility assessment in recognition of its commitment to Corporate Social...

In the precision medicine era, the line between products and services is blurred

White Papers and Resources | September 4, 2020 | Blue Latitude Health

Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?

Leveraging Data, Technology & Expertise to Solve Problems & Transform Healthcare

Videos and Podcasts | September 3, 2020 | Impetus Digital

Tushar Pant, Consulting Executive in Healthcare at IBM, discusses how technology is transforming healthcare. Among many other things, we explore how IBM is working to improve the healthcare industry in Canada,...

Reimagining Healthcare Through Integrated Digital Health Empowerment

Videos and Podcasts | September 3, 2020 | Impetus Digital

Yianni Serpanos, Founder & CEO of HealthTechX, discusses a variety of topics, including how COVID-19 has affected the uptake of telehealth among allied health professionals in Australia and worldwide. Yianni also...

Porterhouse Medical Hub, Nottingham: The latest development for the Porterhouse Medical Group

Press Releases | September 3, 2020 | Porterhouse Medical Group

As part of our continued expansion and the expansion of imc group, Porterhouse Medical Group, global insight-led scientific and medical communications agency, is delighted to announce the opening of our latest...

Digital Therapeutics Landscape in Europe

White Papers and Resources | September 3, 2020 | OPEN Health

OPEN Health introduce an overview of regulatory and HTA developments for digital therapeutics in Europe focusing on Germany and the UK

Live webinar from Singapore

White Papers and Resources | September 2, 2020 | Inizio

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19

OPEN Health’s virtual reflections on the World Orphan Drug Congress US

White Papers and Resources | September 2, 2020 | OPEN Health

Another congress attended in this virtual world with learnings gathered and connections made across the rare disease community. It was great to be joined by many colleagues from all our...

Guide

White Papers and Resources | September 1, 2020 | Inizio

UX research

Article: Why pharma must trust the science of behaviour

White Papers and Resources | September 1, 2020 | Inizio

In a recent interview with PME Magazine, Dan Coffin, Director explains why the application of behavioural science will be key to better health far beyond COVID-19.Read the full article here:...